ST诺泰：建德工厂原料药生产线通过GMP符合性检查

Core Viewpoint - ST诺泰's subsidiary, Hangzhou Ausainuo Biotechnology Co., Ltd., has successfully passed the GMP compliance inspection for the active pharmaceutical ingredient (API) Aogteweina, indicating adherence to quality management standards [1] Group 1 - The Zhejiang Provincial Drug Administration issued a GMP compliance inspection notice (No. 浙2026第0013号) to the company [1] - The inspection covered specific workshops and production lines for the API Aogteweina, including Workshop 1, Workshop 6, Workshop 9, and Production Line B [1] - The conclusion of the inspection confirmed that the production and quality management of the API Aogteweina met the requirements of the Good Manufacturing Practice (GMP) as revised in 2010 [1]